Brian Abrahams' Stock Ratings

RBC Capital Analyst

Brian Abrahams is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

8.53%

Smart Score

66.8%

Overall Average Return Percentile

56th

Number of Ratings

268
Buy NowGet Alert
05/13/2024CRBPBuy Now
Corbus Pharmaceuticals
$45.9667.54% → $77Initiates → OutperformGet Alert
05/07/2024PLRXBuy Now
Pliant Therapeutics
$15.69186.9%$54 → $45MaintainsOutperformGet Alert
05/07/2024VRTXBuy Now
Vertex Pharmaceuticals
$441.96-4.06%$417 → $424MaintainsSector PerformGet Alert
04/30/2024CTNMBuy Now
Contineum Therapeutics
$15.0199.87% → $30Initiates → OutperformGet Alert
04/26/2024SAGEBuy Now
Sage Therapeutics
$11.9026.05%$26 → $15MaintainsSector PerformGet Alert
04/26/2024GILDBuy Now
Gilead Sciences
$67.299.97%$76 → $74MaintainsSector PerformGet Alert
04/15/2024MRNSBuy Now
Marinus Pharma
$1.31128.14%$24 → $3DowngradeOutperform → Sector PerformGet Alert
04/11/2024APLTBuy Now
Applied Therapeutics
$4.58161.72% → $12ReiteratesOutperform → OutperformGet Alert
04/09/2024REGNBuy Now
Regeneron Pharmaceuticals
$971.7922.35% → $1189ReiteratesOutperform → OutperformGet Alert
04/03/2024ITCIBuy Now
Intra-Cellular Therapies
$66.9928.38% → $86ReiteratesOutperform → OutperformGet Alert
03/28/2024NMRABuy Now
Neumora Therapeutics
$9.63221.91% → $31ReiteratesOutperform → OutperformGet Alert
03/26/2024APLTBuy Now
Applied Therapeutics
$4.58161.72% → $12Initiates → OutperformGet Alert
03/25/2024INCYBuy Now
Incyte
$56.7814.48% → $65ReiteratesSector Perform → Sector PerformGet Alert
03/25/2024HOOKBuy Now
HOOKIPA Pharma
$0.84496.66% → $5ReiteratesOutperform → OutperformGet Alert
03/12/2024INCYBuy Now
Incyte
$56.7814.48% → $65ReiteratesSector Perform → Sector PerformGet Alert
03/11/2024SAGEBuy Now
Sage Therapeutics
$11.90118.49% → $26ReiteratesSector Perform → Sector PerformGet Alert
03/08/2024PTCTBuy Now
PTC Therapeutics
$33.15-15.54% → $28ReiteratesSector Perform → Sector PerformGet Alert
03/08/2024NMRABuy Now
Neumora Therapeutics
$9.63221.91%$24 → $31MaintainsOutperformGet Alert
03/08/2024MNMDBuy Now
Mind Medicine
$8.73152.02%$15 → $22MaintainsOutperformGet Alert
03/08/2024IGMSBuy Now
IGM Biosciences
$9.29126.05% → $21ReiteratesOutperform → OutperformGet Alert
03/06/2024MRNSBuy Now
Marinus Pharma
$1.311725.1% → $24ReiteratesOutperform → OutperformGet Alert
03/05/2024PLRXBuy Now
Pliant Therapeutics
$15.69244.28%$50 → $54MaintainsOutperformGet Alert
03/05/2024BIIBBuy Now
Biogen
$226.9160.41% → $364ReiteratesOutperform → OutperformGet Alert
03/01/2024XENEBuy Now
Xenon Pharmaceuticals
$40.4336.04%$56 → $55MaintainsOutperformGet Alert
03/01/2024PTCTBuy Now
PTC Therapeutics
$33.15-15.54%$22 → $28MaintainsSector PerformGet Alert
03/01/2024ETNBBuy Now
89bio
$8.9456.52%$15 → $14MaintainsSector PerformGet Alert
02/29/2024SRPTBuy Now
Sarepta Therapeutics
$131.4519.44%$151 → $157MaintainsOutperformGet Alert
02/29/2024MNMDBuy Now
Mind Medicine
$8.7371.84%$14 → $15MaintainsOutperformGet Alert
02/28/2024PLRXBuy Now
Pliant Therapeutics
$15.69218.78%$53 → $50MaintainsOutperformGet Alert
02/27/2024REGNBuy Now
Regeneron Pharmaceuticals
$971.7921.84%$1096 → $1184MaintainsOutperformGet Alert